Stock Events

Stock Events

Relmada Therapeutics (4E2.F) Q2 2024 Earnings

8MayConfirmed

Q2 2024

-0.79

-0.75

-0.71

-0.67

Details

Expected EPS

-0.790755

Actual EPS

-0.669816

Surprise EPS

0.12

Surprise Percent

+15.29%

Description

Relmada Therapeutics (4E2.F) has reported earnings of -0.669816 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.